This study will look at a study drug called PF-08642534 in people with obesity (have too much body weight) to see: if participants can take different amounts (doses) of the study drug in a safe way and how adults with obesity tolerate it, and how the body handles the study drug (for example, how the study drug is absorbed and removed from the body).
People who want to join the study will first go through a screening period of up to 4 weeks. Doctors will check if each person meets the study conditions, including age, body weight, and general health. People with certain medical conditions will not be able to take part in the study.
Inclusion:
Exclusion:
- Individuals with diabetes, significant cardiovascular, hepatic, renal, gastrointestinal, or psychiatric disorders, or conditions that may affect drug absorption or metabolism, are not eligible to participate.
ClinicalTrials.gov_Inquiries@pfizer.com
Participants will receive matching placebo QD
Participants will receive PF-08642534 QD
A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity
A Study to Learn How the Study Medicine Called PF-08653944 is Taken up Into the Blood in Adults With Overweight or Obesity
A Study to Learn How the Study Medicine Called PF-08653945 is Taken up Into the Blood in Adults With Overweight or Obesity
A Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Obesity
A Multiple Dose Study Of PF-04620110 In Overweight And Obese, Otherwise Healthy Volunteers
A Study Of PF-04620110 As A Modified-Release Formulation In Healthy Overweight Or Obese Subjects
Multiple Dose Study Of PF-05231023 In Obese Adult Subjects
A Study to Learn About the Study Medicine PF-07853578 and How it Acts in the Bodies of Healthy Adults